Castlight Health (CSLT) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Castlight Health Inc. (CSLT) PT Raised to $4.50 at Cowen Following Solid 2Q Results
August 3, 2017 6:59 AM EDTCowen raised its price target on Castlight Health Inc. (NYSE: CSLT) to $4.50 (from $4.00) while maintaining a Market Perform rating. CSLT reported 2Q revenue of $32.1M, ahead of consensus estimates of $31.1M. Revenue was driven by a full quarter contribution from Jiff and strong cross selling... More
